Sundy John 4
4 · Pandion Therapeutics, Inc. · Filed Jul 21, 2020
Insider Transaction Report
Form 4
Sundy John
Chief Medical Officer
Transactions
- Purchase
Common Stock
2020-07-21$18.00/sh+2,000$36,000→ 115,826 total - Award
Stock Option (right to buy)
2020-07-17+145,420→ 145,420 totalExercise: $18.00Exp: 2030-07-16→ Common Stock (145,420 underlying)
Footnotes (2)
- [F1]Represents shares purchased through a directed share program in connection with the initial public offering of Pandion Therapeutics, Inc.'s common stock, which closed on July 21, 2020. These shares of common stock were purchased at the public offering price of $18.00 per share.
- [F2]This option award was granted on July 17, 2020. 1/4 of the shares underlying the award shall vest on May 18, 2021, with the remainder of the shares vesting in equal monthly installments following May 18, 2021 through May 18, 2024, subject to the reporting person's continued service on each applicable vesting date.